Invention Grant
- Patent Title: Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin
-
Application No.: US13809222Application Date: 2011-07-07
-
Publication No.: US10940159B2Publication Date: 2021-03-09
- Inventor: James Trinca Green , William Owen Wilkison
- Applicant: James Trinca Green , William Owen Wilkison
- Applicant Address: US NC Raleigh; US NC Raleigh
- Assignee: James Trinca Green,William Owen Wilkison
- Current Assignee: James Trinca Green,William Owen Wilkison
- Current Assignee Address: US NC Raleigh; US NC Raleigh
- Agency: J.A. Lindeman & Co., PLLC
- International Application: PCT/US2011/043143 WO 20110707
- International Announcement: WO2012/006398 WO 20120112
- Main IPC: A61K31/7056
- IPC: A61K31/7056 ; A61K9/20 ; A61K9/24 ; A61K9/50 ; A61K45/06

Abstract:
A combination immediate/delayed release delivery system for compounds which have short half-life's, such as the antidiabetic remogliflozin etabonate, is provided which provides a dosage form that has two distinct phases of release, a formulation that promotes immediate release of the compound upon ingestion and another formulation which delays the release of the compound so that a dosing regimen of remogliflozin etabonate, once daily, may be achieved while providing effective control of plasma glucose and minimizing the nighttime exposure of this compound. The delivery system includes, but is not limited to, a combination of enteric coating of an immediate release formulation such that a delay in release is provided. Methods for forming the so-described immediate/delayed release delivery system and using such delivery system for treating diabetes are also provided.
Public/Granted literature
Information query